Skip to main content
. 2019 Mar 29;17(4):201. doi: 10.3390/md17040201

Figure 6.

Figure 6

Effect of L1 on the metabolic viability of human breast tissue explants. Tissue explants of human breast tumor from five patients were incubated with DMEM/F12 supplemented medium and treated with L1 at 10 and 30 μg/mL. TX (20 μg/mL) and CIS (50 μg/mL) were used as pharmacological controls. Data are expressed as means ± standard deviation (SD). * p < 0.05 compared to the control; # p < 0.05 compared to TX (20 μg/mL).